Earlier in June, experts from industry and academia gathered for Advarra’s inaugural virtual symposium, discussing hot topics and emerging issues in the gene therapy field. Panelists talked about how gene therapy research can address infectious diseases like coronavirus, the impact of manufacturing challenges on study startup, and ways the research community might overcome obstacles to optimize startup and the overall research process.
Panelists participated in a Q&A session addressing audience members’ questions following the presentation. Due to the volume of questions, our experts have provided responses to some of the most popular topics.
To learn more about Gene Therapy Research in the Age of COVID-19, read the Q&A on Advarra’s website.